T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
1201
DELISTED
Immunogen Inc
IMGN
| $21.5M | ﹤0.01% |
2,270,747
-628,364
| -22% | -$6.04M |
|
|
MYOV
1202
DELISTED
Myovant Sciences Ltd.
MYOV
| $21.5M | ﹤0.01% |
809,380
+134,677
| +20% | +$3.05M |
|
1203
Scholar Rock
SRRK
$6.46B
| $21.4M | ﹤0.01% |
831,729
+244,398
| +42% | +$4.49M |
|
|
CZR
1204
DELISTED
Caesars Entertainment Corporation
CZR
| $21.4M | ﹤0.01% |
2,088,704
-35,057,677
| -94% | -$369M |
|
1205
Leidos
LDOS
$17.9B
| $21.3M | ﹤0.01% |
308,531
+32,209
| +12% | +$2.19M |
|
1206
i3 Verticals
IIIV
$325M
| $21.2M | ﹤0.01% |
924,198
+424,198
| +85% | +$7.58M |
|
1207
Akamai
AKAM
$18B
| $21.2M | ﹤0.01% |
290,319
+1,556
| +0.5% | +$117K |
|
1208
Quanterix
QTRX
$135M
| $21.2M | ﹤0.01% |
989,509
+336
| +0% | +$5.31K |
|
1209
Kinsale Capital Group
KNSL
$8.59B
| $21.2M | ﹤0.01% |
331,464
-1,902
| -0.6% | -$113K |
|
1210
Addus HomeCare
ADUS
$2.2B
| $21.2M | ﹤0.01% |
+301,680
| New | +$19.5M |
|
1211
Hasbro
HAS
$13.6B
| $21.1M | ﹤0.01% |
201,030
-11,900
| -6% | -$1.19M |
|
|
CCRN
1212
DELISTED
Cross Country Healthcare
CCRN
| $21M | ﹤0.01% |
2,410,872
+21,982
| +0.9% | +$224K |
|
1213
Coherus Oncology
CHRS
$176M
| $21M | ﹤0.01% |
1,273,319
-441,637
| -26% | -$7.83M |
|
|
CUTR
1214
DELISTED
Cutera, Inc.
CUTR
| $21M | ﹤0.01% |
645,005
+307,260
| +91% | +$11.2M |
|
1215
Cincinnati Financial
CINF
$26.5B
| $20.9M | ﹤0.01% |
272,150
+7,800
| +3% | +$581K |
|
1216
James River Group Holdings
JRVR
$200M
| $20.7M | ﹤0.01% |
486,773
-2,944
| -0.6% | -$120K |
|
|
KAMN
1217
DELISTED
Kaman Corp
KAMN
| $20.7M | ﹤0.01% |
309,625
-4,292
| -1% | -$284K |
|
|
XEC
1218
DELISTED
CIMAREX ENERGY CO
XEC
| $20.6M | ﹤0.01% |
221,962
-8,356
| -4% | -$767K |
|
1219
Dover
DOV
$27.8B
| $20.5M | ﹤0.01% |
231,520
-24,100
| -9% | -$1.99M |
|
1220
Advance Auto Parts
AAP
$3.46B
| $20.4M | ﹤0.01% |
120,941
-9,600
| -7% | -$1.48M |
|
|
LGF.B
1221
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $20.3M | ﹤0.01% |
870,540
-238,402
| -21% | -$5.36M |
|
|
WLL
1222
DELISTED
Whiting Petroleum Corporation
WLL
| $20.3M | ﹤0.01% |
5,097
+4,892
| +2,386% | +$18M |
|
1223
F5
FFIV
$23.6B
| $20.3M | ﹤0.01% |
101,657
-506
| -0.5% | -$92.6K |
|
|
BZUN
1224
Baozun
BZUN
$168M
| $20.2M | ﹤0.01% |
416,624
-61,676
| -13% | -$3.34M |
|
1225
lululemon athletica
LULU
$13.6B
| $20.2M | ﹤0.01% |
124,385
+12,601
| +11% | +$1.73M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.